ALKS logo Alkermes : ALKS

ALKS

Stock Data

$31.22

Change up

$0.60 (1.96%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Alkermes plc is a biopharmaceutical company based in Dublin, Ireland, focusing on developing treatments for critical unmet medical needs. It specializes in creating innovative therapies for alcohol and opioid dependence, schizophrenia, bipolar I disorder, and other neurological disorders. Its product lineup includes ARISTADA and VIVITROL, among others, aimed at improving patient outcomes. Alkermes also collaborates with leading pharmaceutical companies and leverages proprietary technology platforms to advance its research and development efforts, making significant contributions to the field of medicine since its establishment in 1987.

All Alkermes Articles

91 Articles

1 2 3 7

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.